‎Dallah Health, Fakeeh Care receive GAC approval for Al-Faqih & Partners deal

‎Dallah Health, Fakeeh Care receive GAC approval for Al-Faqih & Partners deal ‎Dallah Health, Fakeeh Care receive GAC approval for Al-Faqih & Partners deal

​‎

Logo of Dallah Healthcare

Dallah Healthcare Co. and Dr. Soliman Abdel Kader Fakeeh Hospital Co. (Fakeeh Care) received, June 11, a no-objection clearance from the General Authority for Competition (GAC), regarding the economic concentration resulting from the proposed deal involving Dr Mohammed bin Rashed Al-Faqih Partners Co.

Advertisement

The deal involves Dallah Health’s sale of its entire stake, representing approximately 31.21% of the share capital of Al-Faqih Partners to Fakeeh Care.

In separate statements to Tadawul, both companies said the deal remains subject to a number of other conditions precedent.

They added that they will announce the completion of the deal once all conditions have been satisfied and will disclose any material developments related to the transaction as they arise.

According to Argaam data, Dallah Healt signed in May 2026 a binding share sale agreement with Fakeeh Care to sell its full 31.21% stake in Al-Faqih Partners.

The deal is valued at SAR 497.98 million, representing the cash consideration payable to Dallah Health.

 

Logo of Dallah Healthcare

Dallah Healthcare Co. and Dr. Soliman Abdel Kader Fakeeh Hospital Co. (Fakeeh Care) received, June 11, a no-objection clearance from the General Authority for Competition (GAC), regarding the economic concentration resulting from the proposed deal involving Dr Mohammed bin Rashed Al-Faqih Partners Co.

The deal involves Dallah Health’s sale of its entire stake, representing approximately 31.21% of the share capital of Al-Faqih Partners to Fakeeh Care.

In separate statements to Tadawul, both companies said the deal remains subject to a number of other conditions precedent.

They added that they will announce the completion of the deal once all conditions have been satisfied and will disclose any material developments related to the transaction as they arise.

According to Argaam data, Dallah Healt signed in May 2026 a binding share sale agreement with Fakeeh Care to sell its full 31.21% stake in Al-Faqih Partners.

The deal is valued at SAR 497.98 million, representing the cash consideration payable to Dallah Health.

Add a comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Keep Up to Date with our Weekly Newsletter

By pressing the Subscribe button, you confirm that you have read and are agreeing to our Privacy Policy and Terms of Use
Advertisement